Virtual Library
Start Your Search
- Virtual Library Home
- IASLC Library
- Explore Event
-
WCLC 2013
15th World Conference on Lung Cancer
Access to all presentations that occurred during the 15th World Conference on Lung Cancer in Sydney, Australia.
Presentation Date(s):- October 27 - 30, 2013
- Total Presentations: 2517
-
+
P1.11 - Poster Session 1 - NSCLC Novel Therapies
- Type: Poster Session
- Track: Medical Oncology
- Presentations: 45
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.11-003 - Exon 19 deletions, smoking history and gender as additional predictive factors for treatment benefit with EGFR Tyrosine Kinase Inhibitors in patients harbouring activating EGFR mutations: A Meta-analysis of 1432 patients in six randomised trials.
09:30 - 09:30 | Author(s): P.N. Ding
- Abstract
Loading...
-
+
P1.24 - Poster Session 1 - Clinical Care
- Type: Poster Session
- Track: Supportive Care
- Presentations: 53
- Coordinates: 10/28/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P1.24-013 - Prophylaxis against pulmonary thromboembolism with unfractionated heparin for the patients undergoing pulmonary resection for lung cancer
09:30 - 09:30 | Author(s): T. Takemoto
- Abstract
Loading...
-
+
O01 - Prognostic and Predictive Biomarkers I
- Type: Oral Abstract Session
- Track: Medical Oncology
- Presentations: 8
- Moderators:T. Mitsudomi
- Coordinates: 10/28/2013, 10:30 - 12:00, Parkside Auditorium, Level 1
-
+
O01.01 - Genetic polymorphisms of inflammatory and DNA repair pathways, radiation-related esophagitis and pneumonitis in definitive chemoradiation treated non-small cell lung cancer patients.
10:30 - 10:40 | Author(s): K. Barrett
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.02 - MicroRNA Signature Predicts Survival in Resectable Small-Cell Lung Cancer
10:40 - 10:50 | Author(s): N. Bi
- Abstract
Loading... -
+
O01.03 - BRM Promoter Variants and Survival Outcomes of Advanced Non-Small Cell Lung Cancer (NSCLC) Patients: A Validation Study in the NCIC Clinical Trials Group (NCIC-CTG) BR24 Clinical Trial
10:50 - 11:00 | Author(s): S. Cuffe
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.04 - DISCUSSANT
11:00 - 11:15 | Author(s): G. Sozzi
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.05 - EGFR wild-type NSCLC patients with high miR-200c expression can benefit from EGFR-TKI
11:15 - 11:25 | Author(s): J. Li
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.06 - Dynamic change in plasma EGFR mutation DNA in response to first line therapy for advanced stage non-small cell lung cancer (NSCLC)
11:25 - 11:35 | Author(s): T. Mok
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.07 - Randomized Proteomic Stratified Phase III Study of Second Line Erlotinib (E) versus Chemotherapy (CT) in Patients with Inoperable Non-Small Cell Lung Cancer (PROSE): Secondary Endpoint Analysis
11:35 - 11:45 | Author(s): V. Gregorc
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login. -
+
O01.08 - DISCUSSANT
11:45 - 12:00 | Author(s): D. Gandara
- Abstract
- Presentation
No abstract available for this presentation
IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
-
+
P2.05 - Poster Session 2 - Preclinical Models of Therapeutics/Imaging
- Type: Poster Session
- Track: Biology
- Presentations: 27
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.05-010 - Several receptor tyrosine kinase is activated but orchestrated by EGFR in EGFR-TKI acquired resistant lung adenocarcinoma cells with EGFR mutation
09:30 - 09:30 | Author(s): K. Suda
- Abstract
Loading...
-
+
P2.06 - Poster Session 2 - Prognostic and Predictive Biomarkers
- Type: Poster Session
- Track: Biology
- Presentations: 50
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.06-033 - Identification f IGF-1R activation as a candidate molecular target in KRAS-mutated lung cancer
09:30 - 09:30 | Author(s): H. Mizuuchi
- Abstract
Loading...
-
+
P2.18 - Poster Session 2 - Pathology
- Type: Poster Session
- Track: Pathology
- Presentations: 23
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.18-008 - Transformation to sarcomatoid carcinoma in ALK-rearranged adenocarcinoma which developed acquired resistance to crizotinib and received subsequent chemotherapies
09:30 - 09:30 | Author(s): Y. Kobayashi
- Abstract
Loading...
-
+
P2.19 - Poster Session 2 - Imaging
- Type: Poster Session
- Track: Imaging, Staging & Screening
- Presentations: 14
- Coordinates: 10/29/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P2.19-010 - The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity
09:30 - 09:30 | Author(s): Y. Kobayashi
- Abstract
Loading...
-
+
P3.09 - Poster Session 3 - Combined Modality
- Type: Poster Session
- Track: Combined Modality
- Presentations: 18
- Coordinates: 10/30/2013, 09:30 - 16:30, Exhibit Hall, Ground Level
-
+
P3.09-007 - Update data of biomarker analysis of WJOG4107 (A randomized phase II trial of adjuvant chemotherapy with S-1 versus CDDP+S-1 for resected stage II-IIIA non-small cell lung cancer (NSCLC))
09:30 - 09:30 | Author(s): H. Tada
- Abstract
Loading...
-
+
E10 - Targeting KRAS in Lung Cancer
- Type: Educational Session
- Track: Biology
- Presentations: 4
- Moderators:C.M. Lovly
- Coordinates: 10/30/2013, 14:00 - 15:30, Parkside Auditorium, Level 1
-
+
E10.1 - Biology
14:05 - 14:30 | Author(s): T. Mitsudomi
- Abstract
- Presentation
Loading...IASLC Members: To view this content or have the option to purchase this event, click here to login.
Conference Attendees & Access Code holders: Click here to enter your Access Code. Already entered your Access Code? Please login.
